We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Amyloid P Promotes Binding to Plastics

By Biotechdaily staff writers
Posted on 31 Oct 2005
Researchers studying how the body responds to materials used in the manufacture of implanted medical devices have determined that serum amyloid P protein binds to plastic materials and induces adhesion and activation of leukocytes.

Investigators at Washington University (St. More...
Louis, MO, USA) used gel electrophoresis, ion trap mass spectrometry, and other advanced proteomics techniques to study the binding of serum proteins to plastics such as polypropylene, polyethylene terephthalate (PET), or polydimethylsiloxane (PDMS) that are components of implanted medical devices.

They found that incubation of the plastic materials with 5% serum for longer than four hours resulted in binding of unexpectedly high amounts of serum amyloid P protein. Previous work had shown that serum amyloid P was constitutively expressed in humans, functioned as an opsonin (a molecule that acts as a binding enhancer for the process of phagocytosis), and interacted with receptors on leukocytes. In the current study, published in the October 1, 2005, issue of the Journal of Biomedical Materials Research, it was found that serum amyloid P adsorbed to polystyrene, PDMS, and PET under tissue culture conditions and promoted the adhesion of granulocytes and monocytes in the presence of calcium.

"No one had ever observed serum amyloid P on biomedical materials before, because, unless you were specifically looking for them, the technology was not around to easily identify proteins present in such small amounts,” explained senior author Dr. Donald Elbert, assistant professor of biomedical engineering at Washington University. "No one, including us, had ever posed the hypothesis that this protein might be important in the biocompatibility of materials. Our results show the importance of large-scale techniques that emphasize discovery of new knowledge, rather than just hypothesis-testing.”



Related Links:
Washington University

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.